Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients
Journal Article
·
· Proceedings of the National Academy of Sciences of the United States of America; (United States)
- Univ. of California, Irvine (United States)
- Genetech Inc., San Francisco, CA (United States)
- John Kennedy Cancer Center, Indio, CA (United States)
- Children's Hospital, Los Angeles, CA (United States)
- Memorial Cancer Inst., Long Beach, CA (United States)
- Univ. of California, Irvine (United States) Memorial Cancer Inst., Long Beach, CA (United States)
Serum ultrafiltrates (SUF) from human patients with different types of cancer contain a blocking factor (BF) that inhibits the cytolytic activity of human tumor necrosis factor {alpha} (TNF-{alpha}) in vitro. BF is a protein with a molecular mass of 28kDa on reducing sodium dodecyl sulfate/polyacrylamide gel electrophoresis (SDS/PAGE). The active material was purified to homogeneity by a combination of affinity chromatography, PAGE, and high-pressure liquid chromatography. Amino acid sequence analysis revealed that BF is derived from the membrane TNF receptor. Purified BF blocks the lytic activity of recombinant human and mouse TNF-{alpha} and recombinant human lymphotoxin activity of TNF-{alpha} and recombinant human lymphotoxin on murine L929 cells in vitro. However, BF inhibits the lytic activity of TNF-{alpha} more effectively than it does that of lymphotoxin. The BF also inhibits the necrotizing activity of recombinant human TNF-{alpha} when coinjected into established cutaneous Meth A tumors in BALB/c mice. The BF may have an important role in (i) the regulation and control of TNF-{alpha} and lymphotoxin activity in cancer patients, (ii) interaction between the tumor and the host antitumor mechanisms, and (iii) use of systemically administered TNF-{alpha} in clinical trials with human cancer patients.
- OSTI ID:
- 5822267
- Journal Information:
- Proceedings of the National Academy of Sciences of the United States of America; (United States), Journal Name: Proceedings of the National Academy of Sciences of the United States of America; (United States) Vol. 87:22; ISSN 0027-8424; ISSN PNASA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Lymphotoxin cytotoxicity, a combination of cytolytic and cytostatic cellular responses
Identification of beta-lymphotoxin as the predominant molecular class of in vitro and in vivo Syrian hamster lymphotoxin
Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein
Journal Article
·
Mon Nov 30 23:00:00 EST 1981
· Immunopharmacology; (United States)
·
OSTI ID:5211623
Identification of beta-lymphotoxin as the predominant molecular class of in vitro and in vivo Syrian hamster lymphotoxin
Journal Article
·
Fri Dec 31 23:00:00 EST 1982
· Cell. Immunol.; (United States)
·
OSTI ID:6253259
Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein
Journal Article
·
Mon Oct 01 00:00:00 EDT 1990
· Proceedings of the National Academy of Sciences of the United States of America; (USA)
·
OSTI ID:5685259